Subjects with anterior acute STEMI who receive an IABC before primary PCI will have decreased MI size.
Post clearance device study in which subjects with acute MI will be randomized 1:1 to either receive IAB or to receive standard of care without IAB before mechanical reperfusion. Subjects will be followed throughout their hospital stay and at 30 days.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
339
IABC pre-reperfusion PCI
To determine whether IABC before mechanical reperfusion decreases myocardial infarct (MI) size.
Time frame: 3-5 days
To determine the effect of IABC before mechanical reperfusion on post PCI cardiovascular function and major adverse cardiac events (MACE) (ie, death, reinfarction, and CHF) at 30 days and 6 months.
Time frame: 30 days and 6 months post randomization
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
University of Alabama at Birmingham
Birmingham, Alabama, United States
University of Southern California
Los Angeles, California, United States
Washington Hospital Center
Washington D.C., District of Columbia, United States
Cleveland Clinic Florida
Weston, Florida, United States
Tufts Medical Center
Boston, Massachusetts, United States
Caritas St. Elizabeth's Medical Center
Boston, Massachusetts, United States
Essentia Institute of Rural Health (St Mary's)
Duluth, Minnesota, United States
University of Nebraska Medical Center
Omaha, Nebraska, United States
University of Medicine and Dentistry of New Jersey
Newark, New Jersey, United States
Newark Beth Israel Hospital
Newark, New Jersey, United States
...and 30 more locations